Elevation Oncology
ELEV
₹22.04
Share price
-1.34%
Change (1 day)
-94.89%
Change (1 year)
Categories
Elevation Oncology (ELEV) - P/B ratio
P/B ratio as of April 2025 : 0.2550
According to Elevation Oncology's latest financial reports the company has a price-to-book ratio of 0.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Elevation Oncology - P/B ratio (from 2021 to 2024)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2024-12-31 | 0.5845 | 40.66% |
| 2023-12-31 | 0.4156 | -7.95% |
| 2022-12-31 | 0.4515 | -54.57% |
| 2021-12-31 | 0.9938 | |
| 2020-12-31 | N/A |